Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | Edelweiss |
| NAV | ₹40.2296 | ₹36.4592 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.9 years | 8.7 years |
| Expense ratio | 1.1% | 1.4% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 67.50 | 45.20 |
Returns
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 1 month | +9.87% | +5.92% |
| 3 months | +1.12% | +2.40% |
| 6 months | +7.63% | +20.35% |
| YTD | +13.73% | +25.20% |
| 1 year | +11.82% | +23.75% |
| 3 years (CAGR) | +18.74% | +17.13% |
| 5 years (CAGR) | +16.00% | +11.04% |
| 10 years (CAGR) | +15.95% | — |
| Since launch | +13.58% | +15.95% |
Risk
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Volatility | 15.7% | 20.9% |
| Downside volatility | 10.0% | 12.9% |
| Sharpe | 0.78 | 0.51 |
| Sortino | 1.23 | 0.82 |
| Calmar | 1.12 | 0.69 |
| Return / risk | 1.19 | 0.82 |
| Deepest fall | −19.84% | −32.34% |
| Days to recover | 375 | 155 |
| Below its high | +0.00% | −1.63% |
Against benchmark
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Alpha | −2.76% | +5.69% |
| Beta | 1.00 | 0.97 |
| R² | 90.2% | 56.3% |
| Up capture | 91.7% | 114.2% |
| Down capture | 101.4% | 93.5% |
| Tracking error | 4.9% | 13.8% |
| Information ratio | −0.57 | 0.40 |
| Treynor | 0.11 | 0.10 |
Consistency
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Best 1-year | +76.35% | +98.01% |
| Middle 1-year | +8.85% | +17.30% |
| Worst 1-year | −17.32% | −23.25% |
| 1-year periods with a loss | 29.0% | 23.7% |
| Middle 3-year | +21.13% | +18.97% |
| Positive months | 63.9% | 66.7% |
| Best day | +3.34% | +3.68% |
| Worst day | −3.09% | −5.79% |
| Worst 5% day | −1.35% | −1.93% |
| Positive days | 55.4% | 57.6% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 5-year XIRR | +18.07% | +17.87% |
| 5-year value | ₹9,50,065 | ₹9,45,521 |
| 3-year XIRR | +13.31% | +18.35% |
| 1-year XIRR | +18.41% | +35.31% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.